|
Fusion gene ID: 28062 |
FusionGeneSummary for POU6F2_AOAH |
Fusion gene summary |
Fusion gene information | Fusion gene name: POU6F2_AOAH | Fusion gene ID: 28062 | Hgene | Tgene | Gene symbol | POU6F2 | AOAH | Gene ID | 11281 | 313 |
Gene name | POU class 6 homeobox 2 | acyloxyacyl hydrolase | |
Synonyms | RPF-1|WT5|WTSL | - | |
Cytomap | 7p14.1 | 7p14.2 | |
Type of gene | protein-coding | protein-coding | |
Description | POU domain, class 6, transcription factor 2Wilms tumor suppressor locusretina-derived POU-domain factor-1 | acyloxyacyl hydrolaseacyloxyacyl hydrolase (neutrophil) | |
Modification date | 20180403 | 20180523 | |
UniProtAcc | P78424 | P28039 | |
Ensembl transtripts involved in fusion gene | ENST00000403058, ENST00000518318, ENST00000517348, ENST00000559001, ENST00000464276, | ENST00000535891, ENST00000258749, ENST00000431169, ENST00000538464, ENST00000491444, | |
Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 6 X 6 X 4=144 |
# samples | 3 | 7 | |
** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(7/144*10)=-1.04064198449735 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: POU6F2 [Title/Abstract] AND AOAH [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | AOAH | GO:0006631 | fatty acid metabolic process | 1883828|29343645 |
Tgene | AOAH | GO:0009104 | lipopolysaccharide catabolic process | 1883828|29343645 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | GBM | TCGA-26-A7UX-01B | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000403058 | ENST00000535891 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000403058 | ENST00000258749 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000403058 | ENST00000431169 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000403058 | ENST00000538464 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
5CDS-5UTR | ENST00000403058 | ENST00000491444 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000518318 | ENST00000535891 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000518318 | ENST00000258749 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000518318 | ENST00000431169 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000518318 | ENST00000538464 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
5CDS-5UTR | ENST00000518318 | ENST00000491444 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
intron-3CDS | ENST00000517348 | ENST00000535891 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
intron-3CDS | ENST00000517348 | ENST00000258749 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
intron-3CDS | ENST00000517348 | ENST00000431169 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
intron-3CDS | ENST00000517348 | ENST00000538464 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
intron-5UTR | ENST00000517348 | ENST00000491444 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000559001 | ENST00000535891 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000559001 | ENST00000258749 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000559001 | ENST00000431169 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Frame-shift | ENST00000559001 | ENST00000538464 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
5CDS-5UTR | ENST00000559001 | ENST00000491444 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
intron-3CDS | ENST00000464276 | ENST00000535891 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
intron-3CDS | ENST00000464276 | ENST00000258749 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
intron-3CDS | ENST00000464276 | ENST00000431169 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
intron-3CDS | ENST00000464276 | ENST00000538464 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
intron-5UTR | ENST00000464276 | ENST00000491444 | POU6F2 | chr7 | 39503983 | + | AOAH | chr7 | 36571950 | - |
Top |
FusionProtFeatures for POU6F2_AOAH |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
POU6F2 | AOAH |
Probable transcription factor likely to be involved inearly steps in the differentiation of amacrine and ganglion cells.Recognizes and binds to the DNA sequence 5'-ATGCAAAT-3'. Isoform 1does not bind DNA. | Removes the secondary (acyloxyacyl-linked) fatty acylchains from the lipid A region of bacterial lipopolysaccharides(PubMed:1883828, PubMed:8089145, PubMed:29343645). By breakingdown LPS, terminates the host response to bacterial infection andprevents prolonged and damaging inflammatory responses (Bysimilarity). In peritoneal macrophages, seems to be important forrecovery from a state of immune tolerance following infection byGram-negative bacteria (By similarity).{ECO:0000250|UniProtKB:O35298, ECO:0000269|PubMed:1883828,ECO:0000269|PubMed:29343645, ECO:0000269|PubMed:8089145}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for POU6F2_AOAH |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for POU6F2_AOAH |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
POU6F2 | AOAH |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for POU6F2_AOAH |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for POU6F2_AOAH |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | POU6F2 | C0004352 | Autistic Disorder | 1 | CTD_human |
Hgene | POU6F2 | C1832099 | Wilms tumor and radial bilateral aplasia | 1 | CTD_human;UNIPROT |
Tgene | AOAH | C0236733 | Amphetamine-Related Disorders | 1 | CTD_human |